Cellular copper import by nanocarrier systems, intracellular availability, and effects on amyloid β peptide secretion

Biochemistry

Volumn 48, Issue 20, 2009, Pages 4273-4284

  Treiber, Carina ^a   Quadir, Mohiuddin Abdul ^a   Voigt, Philipp ^b   Radowski, Michal ^a   Xu, Shangjie ^a   Munter, Lisa Marie ^a   Bayer, Thomas A ^c   Schaefer, Michael ^b,d   Haag, Rainer ^a   Multhaup, Gerd ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER'S DISEASE; CELLULAR MEMBRANES; CELLULAR UPTAKE; CLATHRIN; COMPLEXING AGENTS; CONCENTRATION GRADIENTS; CORE-MULTISHELL NANOPARTICLES; CORE-SHELL; CORE-SHELL NANOPARTICLES; CYTOSOLIC COMPARTMENTS; ENERGY DEPENDENT; EUKARYOTIC CELLS; GUEST MOLECULES; INTRACELLULAR ORGANELLE; MODIFYING EFFECTS; NANOCARRIER; NANOCARRIERS; PEPTIDE SECRETION; PHYSIOLOGICAL CONDITION; PLASMA MEMBRANES; SUBLETHAL DOSE; UPTAKE SYSTEMS;

AMINES; ANIMALS; GLYCOPROTEINS; METAL IONS; NANOPARTICLES; SOLENOIDS;

CELL MEMBRANES;

AMYLOID BETA PROTEIN; COPPER; NANOCARRIER; NANOPARTICLE;

ARTICLE; CELL MEMBRANE TRANSPORT; CELL TRANSPORT; CELLULAR DISTRIBUTION; ENDOCYTOSIS; INTRACELLULAR TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; TRANSPORT KINETICS; YEAST CELL;

AMYLOID BETA-PROTEIN; ANIMALS; BIOLOGICAL TRANSPORT; CHO CELLS; COPPER; CRICETINAE; CRICETULUS; DRUG CARRIERS; ENDOCYTOSIS; FLUORESCENT DYES; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; PEPTIDES; POLYMERS;

ANIMALIA; EUKARYOTA;

EID: 66149175672     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi900290c     Document Type: Article

References (54)

1. Pena, M. M., Lee, J., and Thiele, D. J. (1999) A delicate balance: Homeostatic control of copper uptake and distribution. J. Nutr. 129, 1251-1260.
2. Keen, C. L., Uriu-Hare, J. Y., Hawk, S. N., Jankowski, M. A., Daston, G. P., Kwik-Uribe, C. L., and Rucker, R. B. (1998) Effect of copper deficiency on prenatal development and pregnancy outcome. Am. J. Clin. Nutr. 67, 1003S-1011S.
3. Ponka, P. (2004) Hereditary causes of disturbed iron homeostasis in the central nervous system. Ann. N.Y. Acad. Sci. 1012, 267-281. (Pubitemid 38453531)
4. Waggoner, D. J., Bartnikas, T. B., and Gitlin, J. D. (1999) The role of copper in neurodegenerative disease. Neurobiol. Dis. 6, 221-230. (Pubitemid 29470034)
5. de Bie, P., Muller, P., Wijmenga, C., and Klomp, L. W. (2007) Molecular pathogenesis of Wilson and Menkes disease: Correlation of mutations with molecular defects and disease phenotypes. J. Med. Genet. 44, 673-688.
6. Bush, A. I., Pettingell, W. H., Multhaup, G., d Paradis, M., Vonsattel, J. P., Gusella, J. F., Beyreuther, K., Masters, C. L., and Tanzi, R. E. (1994) Rapid induction of Alzheimer Aβ amyloid formation by zinc. Science 265, 1464-1467.
7. Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., and Markesbery, W. R. (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158, 47-52.
8. Kang, J., Lemaire, H. G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K. H., Multhaup, G., Beyreuther, K., and Muller-Hill, B. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736. (Pubitemid 17054046)
9. Selkoe, D. J., Yamazaki, T., Citron, M., Podlisny, M. B., Koo, E. H., Teplow, D. B., and Haass, C. (1996) The role of APP processing and trafficking pathways in the formation of amyloid β-protein. Ann. N. Y. Acad. Sci. 777, 57-64. (Pubitemid 26149170)
10. Hesse, L., Beher, D., Masters, C. L., and Multhaup, G. (1994) The βA4 amyloid precursor protein binding to copper. FEBS Lett. 349, 109-116. (Pubitemid 2119590)
11. Multhaup, G., Schlicksupp, A., Hesse, L., Beher, D., Ruppert, T., Masters, C. L., and Beyreuther, K. (1996) The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper (I). Science 271, 1406-1409.
12. White, A. R., Reyes, R., Mercer, J. F., Camakaris, J., Zheng, H., Bush, A. I., Multhaup, G., Beyreuther, K., Masters, C. L., and Cappai, R. (1999) Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice. Brain Res. 842, 439-444. (Pubitemid 29475178)
13. Bayer, T. A., Schafer, S., Simons, A., Kemmling, A., Kamer, T., Tepest, R., Eckert, A., Schussel, K., Eikenberg, O., Sturchler-Pierrat, C., Abramowski, D., Staufenbiel, M., and Multhaup, G. (2003) Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Aβ production in APP23 transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 100, 14187-14192.
14. Bellingham, S. A., Lahiri, D. K., Maloney, B., La Fontaine, S., Multhaup, G., and Camakaris, J. (2004) Copper depletion down-regulates expression of the Alzheimer's disease amyloid-β precursor protein gene. J. Biol. Chem. 279, 20378-20386.
15. Treiber, C., Simons, A., Strauss, M., Hafner, M., Cappai, R., Bayer, T. A., and Multhaup, G. (2004) Clioquinol mediates copper uptake and counteracts copper efflux activities of the amyloid precursor protein of Alzheimer's disease. J. Biol. Chem. 279, 51958-51964. (Pubitemid 39656565)
16. Phinney, A. L., Drisaldi, B., Schmidt, S. D., Lugowski, S., Coronado, V., Liang, Y., Horne, P., Yang, J., Sekoulidis, J., Coomaraswamy, J., Chishti, M. A., Cox, D. W., Mathews, P. M., Nixon, R. A., Carlson, G. A., St George-Hyslop, P., and Westaway, D. (2003) In vivo reduction of amyloid-β by a mutant copper transporter. Proc. Natl. Acad. Sci. U.S.A. 100, 14193-14198.
17. Kessler, H., Bayer, T. A., Bach, D., Schneider-Axmann, T., Supprian, T., Herrmann, W., Haber, M., Multhaup, G., Falkai, P., and Pajonk, F. G. (2008) Intake of copper has no effect on cognition in patients with mild Alzheimer's disease: A pilot phase 2 clinical trial. J. Neural Transm. 115, 1181-1187.
18. Adlard, P. A., Cherny, R. A., Finkelstein, D. I., Gautier, E., Robb, E., Cortes, M., Volitakis, I., Liu, X., Smith, J. P., Perez, K., Laughton, K., Li, Q. X., Charman, S. A., Nicolazzo, J. A., Wilkins, S., Deleva, K., Lynch, T., Kok, G., Ritchie, C. W., Tanzi, R. E., Cappai, R., Masters, C. L., Barnham, K. J., and Bush, A. I. (2008) Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Aβ. Neuron 59, 43-55.
19. Filomeni, G., Cerchiaro, G., Da Costa Ferreira, A. M., De Martino, A., Pedersen, J. Z., Rotilio, G., and Ciriolo, M. R. (2007) Pro-apoptotic activity of novel Isatin-Schiff base copper(II) complexes depends on oxidative stress induction and organelle-selective damage. J. Biol. Chem. 282, 12010-12021. (Pubitemid 47100713)
20. Lee, J. Y., Friedman, J. E., Angel, I., Kozak, A., and Koh, J. Y. (2004) The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human β-amyloid precursor protein transgenic mice. Neurobiol. Aging 25, 1315-1321.
21. Matsumura, Y. (2006) [Micelle carrier system in clinical trial]. Nippon Rinsho 64, 316-321.
22. Nakanishi, T., Fukushima, S., Okamoto, K., Suzuki, M., Matsumura, Y., Yokoyama, M., Okano, T., Sakurai, Y., and Kataoka, K. (2001) Development of the polymer micelle carrier system for doxorubicin. J. Controlled Release 74, 295-302. (Pubitemid 32727635)
23. Duncan, R. (2006) Polymer conjugates for drug targeting. From inspired to inspiration!. J. Drug Targeting 14, 333-335.
24. Radowski, M. R., Shukla, A., von Berlepsch, H., Böttcher, C., Pickaert, G., Rehage, H., and Haag, R. (2007) Supramolecular aggregates of dendritic multishell architectures as universal nanocarriers. Angew. Chem., Int. Ed. 46, 1265-1269. (Pubitemid 46981371)
25. Kräamer, M., Pérignon, N., Haag, R., Marty, J.-D., Thomann, R., Lauth-de Viguerie, N., and Mingotaud, C. (2005) Water-Soluble Dendritic Architectures with Carbohydrate Shells for the Templation and Stabilization of Catalytically Active Metal Nanoparticles. Macromolecules 38, 8308-8315.
26. Crooks, R. M., Zhao, M., Sun, L., Chechik, V., and Yeung, L. K. (2001) Dendrimer-encapsulated metal nanoparticles: Synthesis, characterization, and applications to catalysis. Acc. Chem. Res. 34, 181-190.
27. Simons, A., Ruppert, T., Schmidt, C., Schlicksupp, A., Pipkorn, R., Reed, J., Masters, C. L., White, A. R., Cappai, R., Beyreuther, K., Bayer, T. A., and Multhaup, G. (2002) Evidence for a copper-binding superfamily of the amyloid precursor protein. Biochemistry 41, 9310-9320.
28. Munter, L. M., Voigt, P., Harmeier, A., Kaden, D., Gottschalk, K. E., Weise, C., Pipkorn, R., Schaefer, M., Langosch, D., and Multhaup, G. (2007) GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Aβ42. EMBO J. 26, 1702-1712. (Pubitemid 46480941)
29. Wong, B. S., Pan, T., Liu, T., Li, R., Gambetti, P., and Sy, M. S. (2000) Differential contribution of superoxide dismutase activity by prion protein in vivo. Biochem. Biophys. Res. Commun. 273, 136-139. (Pubitemid 30426875)
30. Culotta, V. C., Yang, M., and O'Halloran, T. V. (2006) Activation of superoxide dismutases: Putting the metal to the pedal. Biochim. Biophys. Acta 1763, 747-758.
31. Borchardt, T., Camakaris, J., Cappai, R., Masters, C. L., Beyreuther, K., and Multhaup, G. (1999) Copper inhibits β-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion. Biochem. J. 344(Part 2), 461-467.
32. Zhao, G., and Lin, H. (2005) Metal complexes with aromatic N-containing ligands as potential agents in cancer treatment. Curr. Med. Chem. Anticancer Agents 5, 137-147.
33. Kumar, N. (2006) Copper deficiency myelopathy (human swayback). Mayo Clin. Proc. 81, 1371-1384. (Pubitemid 44484976)
34. Maynard, C. J., Bush, A. I., Masters, C. L., Cappai, R., and Li, Q. X. (2005) Metals and amyloid-β in Alzheimer's disease. Int. J. Exp. Pathol. 86, 147-159.
35. Duncan, R., and Izzo, L. (2005) Dendrimer biocompatibility and toxicity. Adv. Drug Delivery Rev. 57, 2215-2237. (Pubitemid 41759394)
36. Haag, R., Sunder, A., and Stumbé, J. F. (2000) An Approach to Glycerol Dendrimers and Pseudo-Dendritic Polyglycerols. J. Am. Chem. Soc. 122, 2954-2955. (Pubitemid 30191060)
37. Xu, S., Krämer, M., and Haag, R. (2006) pH-Responsive dendritic core-shell architectures as amphiphilic nanocarriers for polar drugs. J. Drug Targeting 14, 367-374. (Pubitemid 44203517)
38. Donnelly, P. S., Caragounis, A., Du, T., Laughton, K. M., Volitakis, I., Cherny, R. A., Sharples, R. A., Hill, A. F., Li, Q. X., Masters, C. L., Barnham, K. J., and White, A. R. (2008) Selective intracellular release of copper and zinc ions from bis(thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-β peptide. J. Biol. Chem. 283, 4568-4577.
39. White, A. R., Du, T., Laughton, K. M., Volitakis, I., Sharples, R. A., Xilinas, M. E., Hoke, D. E., Holsinger, R. M., Evin, G., Cherny, R. A., Hill, A. F., Barnham, K. J., Li, Q. X., Bush, A. I., and Masters, C. L. (2006) Degradation of the Alzheimer disease amyloid β-peptide by metal-dependent up-regulation of metalloprotease activity. J. Biol. Chem. 281, 17670-17680. (Pubitemid 44035565)
40. Maynard, C. J., Cappai, R., Volitakis, I., Cherny, R. A., White, A. R., Beyreuther, K., Masters, C. L., Bush, A. I., and Li, Q. X. (2002) Overexpression of Alzheimer's disease amyloid-β opposes the agedependent elevations of brain copper and iron. J. Biol. Chem. 277, 44670-44676.
41. Ritchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q. X., Tammer, A., Carrington, D., Mavros, C., Volitakis, I., Xilinas, M., Ames, D., Davis, S., Beyreuther, K., Tanzi, R. E., and Masters, C. L. (2003) Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Aβ amyloid deposition and toxicity in Alzheimer disease: A pilot phase 2 clinical trial. Arch. Neurol. 60, 1685-1691. (Pubitemid 37521621)
42. Lannfelt, L., Blennow, K., Zetterberg, H., Batsman, S., Ames, D., Harrison, J., Masters, C. L., Targum, S., Bush, A. I., Murdoch, R., Wilson, J., and Ritchie, C. W. (2008) Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: A phase IIa, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 7, 779-786.
43. Jansen, J. F. G. A., Meijer, E. W., and de Brabander-van den Berg, E. M. M. (1995) The Dendritic Box: Shape-Selective Liberation of Encapsulated Guests. J. Am. Chem. Soc. 117, 4417-4418.
44. Krämer, M., Stumbe, J. F., Turk, H., Krause, S., Komp, A., Delineau, L., Prokhorova, S., Kautz, H., and Haag, R. (2002) pH-responsive molecular nanocarriers based on dendritic core-shell architectures. Angew. Chem., Int. Ed. 41, 4252-4256. (Pubitemid 35398245)
45. Prohaska, J. R., and Gybina, A. A. (2004) Intracellular copper transport in mammals. J. Nutr. 134, 1003-1006. (Pubitemid 38619931)
46. Thinakaran, G., and Koo, E. H. (2008) Amyloid precursor protein trafficking, processing, and function. J. Biol. Chem. 283, 29615-29619.
47. Chen, D., Peng, F., Cui, Q. C., Daniel, K. G., Orlu, S., Liu, J., and Dou, Q. P. (2005) Inhibition of prostate cancer cellular proteasome activity by a pyrrolidine dithiocarbamate-copper complex is associated with suppression of proliferation and induction of apoptosis. Front. Biosci. 10, 2932-2939. (Pubitemid 40910532)
48. Daniel, K. G., Gupta, P., Harbach, R. H., Guida, W. C., and Dou, Q. P. (2004) Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells. Biochem. Pharmacol. 67, 1139-1151. (Pubitemid 38296793)
49. Dearling, J. L., Lewis, J. S., Mullen, G. E., Welch, M. J., and Blower, P. J. (2002) Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: Structure-activity relationships. J. Biol. Inorg. Chem. 7, 249-259.
50. Green, M. A., Klippenstein, D. L., and Tennison, J. R. (1988) Copper (II) bis(thiosemicarbazone) complexes as potential tracers for evaluation of cerebral and myocardial blood flow with PET. J. Nucl. Med. 29, 1549-1557. (Pubitemid 18213818)
51. Laforest, R., Dehdashti, F., Lewis, J. S., and Schwarz, S. W. (2005) Dosimetry of 60/61/62/64Cu-ATSM: A hypoxia imaging agent for PET. Eur. J. Nucl. Med. Mol. Imaging 32, 764-770.
52. Petris, M. J., Smith, K., Lee, J., and Thiele, D. J. (2003) Copper-stimulated endocytosis and degradation of the human copper transporter, hCtr1. J. Biol. Chem. 278, 9639-9646.
53. Puig, S., Lee, J., Lau, M., and Thiele, D. J. (2002) Biochemical and genetic analyses of yeast and human high affinity copper transporters suggest a conserved mechanism for copper uptake. J. Biol. Chem. 277, 26021-26030.
54. Quadir, M. A., Radowski, M. R., Kratz, F., Licha, K., Hauff, P., and Haag, R. (2008) Dendritic multishell architectures for drug and dye transport. J. Controlled Release 132, 289-294.